HEART FAILURE NYHA CLASS II
Clinical trials for HEART FAILURE NYHA CLASS II explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS II trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a neck implant be the lifeline heart failure patients need?
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves in the neck to help the heart work better. It involves 2,500 adults with moderate heart failure who still have symptoms despite standard treatments. The goal is to see if the device reduces deaths and hospital stays…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
Can special exercise or laser therapy boost heart health in heart failure patients?
Symptom relief OngoingThis study tests two treatments—blood flow restricted resistance exercises and low-level laser therapy—to see if they improve heart function in people with chronic heart failure. Sixty patients aged 40-60 with mild heart failure will be assigned to one of the treatments for 12 we…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Heart failure study unlocks metabolic secrets of common drug
Knowledge-focused OngoingThis study looks at how SGLT2 inhibitors, a type of diabetes drug also used for heart failure, affect the body's metabolism. About 40 adults with mild to moderate heart failure will have blood tests, walking tests, and calf MRIs before and after starting the medication. The goal …
Matched conditions: HEART FAILURE NYHA CLASS II
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC